Treatment possible after positive liquid biopsy in primary central nervous lymphoma patients

A group led by the Department of Neurosurgery at the Brain Research Institute, Niigata University, has successfully diagnosed ...
BioProcess International

Regulatory Frameworks for Central Nervous System Safety Assessment: Bridging Traditional Methods and New Modalities

Despite new methodologies and flexible regulatory pathways, CNS biopharmaceuticals still face significant safety assessment ...
MPR

FDA Places Clinical Hold on Gene Therapies for MPS I and MPS II

An AAV vector genome integration event associated with PLAG1 overexpression was identified in a preliminary analysis of the resected tumor.
News Medical

Understanding the Nervous System Dysregulation

Each part of the nervous system uses internal checks and balances to regulate its activity, responding to various factors like mood, health status, and the external environment.¹ These regulatory ...
CNN

Surprising jellyfish finding challenges what’s known about learning and memory

Sign up for CNN’s Wonder Theory science newsletter. Explore the universe with news on fascinating discoveries, scientific advancements and more. Caribbean box ...
Rutland Herald

Aytu BioPharma to Report Fiscal 2026 Second Quarter Operational and Financial Results on February 3, 2026

DENVER, CO / / January 27, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous ...